Physician profile
Gary Sajko
NPI 1043365406
$2,381.35
in general payments reported to CMS, 2019-2025
16 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $291 · 2021: $251 · 2022: $503 · 2023: $354 · 2024: $109 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $409.25 | 2019-2021 | |
| Allergan, INC. | $377.62 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $364.98 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $217.36 | 2022-2023 | Acthar |
| Abbvie INC. | $179.71 | 2022-2025 | Lumigan, Alphagan P, Durysta |
| Horizon Therapeutics Plc | $167.02 | 2021-2022 | |
| Shire North American Group INC | $135.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $120.82 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $111.88 | 2025 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $92.30 | 2023 | Seglentis |
| Lilly USA, LLC | $89.94 | 2024 | Zepbound |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.79 | 2019-2021 | |
| Alcon Vision LLC | $19.88 | 2025 | |
| Harrow Eye, LLC | $18.80 | 2024 | Vevye |
| Biotissue Holdings INC. | $17.88 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $15.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Sajko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.